查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375987

尿道感染检测市场规模、份额和趋势分析报告：按类型、最终用途、地区、细分市场趋势，2023-2030 年

Urinary Tract Infection Testing Market Size, Share & Trends Analysis Report By Type (Urethritis, Cystitis, Pyelonephritis), By End Use (Reference Laboratories, General Practitioners, Urologists, Urgent Care), By Region, & Segment Forecasts, 2023-2030
出版日期: | 出版商: Grand View Research | 英文 113 Pages | 商品交期: 2-10个工作天内

价格

尿道感染检测市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球尿道感染检测市场规模预计将达到8.1201亿美元。

预计 2023 年至 2030 年该市场将以 4.4% 的年复合成长率成长。尿道感染(UTI) 检测市场受到不断上升的疾病负担、不断增长的老年人口、快速的技术进步以及自我检测和快速护理点 (PoC) 设备产品等新颖和创新产品的推动。增长归因于主要企业实施高额研发投入等因素。

尿道感染正成为全世界共同关注的问题。研究表明，五分之一的成年女性一生中至少会患上一次尿道感染。在美国，大约 25% 至 40% 的 20 至 40 岁女性患有尿道结石。美国每年报告约 25 万例肾盂肾炎病例。在18至19岁的女性中，发生率约为28/10,000，其中7%的病例需要住院治疗。遗传和文化因素可能会影响其盛行率，例如在韩国，肾盂肾炎的发生率约为 59/10,000。男性復发率为 5.7%，女性復发率为 9%，比其他尿道结石更常见。

全球糖尿病盛行率的不断上升可能导致膀胱炎的增加，因为糖尿病患者罹患急性膀胱炎等尿道感染的风险更高。根据 NCBI 论文，2 型糖尿病会增加尿道结石的风险，且第 2 型糖尿病患者会频繁出现严重的尿道结石。根据国际糖尿病联盟（IDF）2021年的资料，到2030年，大约有6.43亿人将受到糖尿病的影响，到2045年，大约有7.83亿人将受到糖尿病的影响。此外，糖尿病女性中无症状性菌尿的盛行率估计为 26%，而非糖尿病女性中无症状菌尿的盛行率为 6%。预计这些因素将增加全世界膀胱炎的盛行率。

然而，随着人们对这些疾病的认识不断提高，近年来对专科治疗的需求也随之增加。根据美国卫生与公共服务部的数据，2020年美国执业泌尿系统的数量为每10万人中4.07人。报告进一步指出，由于需求增加，泌尿系统出现短缺，到 2025 年，医生数量可能会超过近 3,600 名。这可能会阻碍未来年度的市场成长。此外，COVID-19 也对该行业产生了负面影响。尿道结石患者对检测和紧急医疗护理构成重大障碍。

主要企业正在推出新产品来增强其产品组合。例如，2021 年 9 月，OpGen, Inc. 宣布启动 Unyvero 泌尿道感染小组的临床试验。此面板可以直接从尿液样本分析多种病原体和抗菌素抗药性标记物。成功的临床试验和此类技术先进、高效产品的推出预计将推动未来年度的市场成长。同样，2020年7月，泌尿系统健康生物技术公司Uqora (Pharmavite, LLC)推出了尿道结石诊断和管理套件。该套件包括 Clarify，这是一种与 PoC 和居家照护相容的快速尿道结石诊断设备。

尿道感染检测市场亮点

  • 膀胱炎占据市场主导地位，预计 2022 年市场占有率为 41.42%。这是由于膀胱炎的盛行率和復发率较高，产品核可数量不断增加，以及大量的糖尿病患者易患膀胱炎。
  • 参考实验室部门在 2022 年占据 26.66% 的份额，因为参考实验室继续努力透过提供零售层面的诊断设施来改善患者的治疗结果。
  • 以金额为准，北美在整个尿道感染市场中占据主导地位。这是由于更好的报销设施以及由于意识的提高而更多地采用新型诊断产品。

目录

第1章调查方法和范围

第2章执行摘要

第3章感染检测市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 尿道感染检测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章感染检测：按类型估计和趋势分析

  • 尿道感染检测市场：重点
  • 尿道感染检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 尿道炎
    • 2018年至2030年尿道炎市场估计与预测
  • 膀胱炎
    • 2018年至2030年膀胱炎市场估计与预测
  • 肾盂肾炎
    • 2018年至2030年肾盂肾炎市场估计与预测

第5章感染检测：依最终用途分类的估算与趋势分析

  • 尿道感染检测市场：重点
  • 尿道感染检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 全科医生（GP）
  • 泌尿系统
  • 泌尿妇科医生
  • 医院实验室
  • 参考实验室
  • 医院急诊部门
  • 紧急护理
  • 其他的

第6章感染检测市场：按地区估算及趋势分析

  • 区域展望
  • 尿道感染检测市场：按地区分類的要点
  • 北美洲
    • 2018-2030 年市场估计与预测
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第7章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • QIAGEN
    • Accelerate Diagnostics, Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • Siemens Healthcare GmbH
    • Randox Laboratories Ltd.
    • Thermo Fisher Scientific, Inc.
    • BIOMERIEUX
    • T2 Biosystems, Inc.
Product Code: GVR-4-68039-951-8

Urinary Tract Infection Testing Market Growth & Trends:

The global urinary tract infection testing market is expected to reach USD 812.01 million by 2030, according to a new report by Grand View Research, Inc.. The market is anticipated to grow at a CAGR of 4.4% from 2023 to 2030. The urinary tract infection (UTI) testing market is witnessing growth due to factors such as rising disease burden, increasing geriatric population, rapid technological advancements, and high R&D investments by key players to introduce novel & innovative products, such as self-testing & rapid Point-of-Care (PoC) devices products.

Urinary tract infection is becoming a common global concern. According to research studies, UTI occurs in one in five adult women at some point in their life. In the U.S., about 25%-40% of women aged 20-40 have suffered a UTI. In the U.S., about 250,000 cases of pyelonephritis are reported every year. In women aged 18-19, its incidence is about 28/10,000, out of which 7% of cases require hospital admission. Genetic and cultural factors may influence its prevalence; for instance, in South Korea, the incidence of pyelonephritis is around 59/10,000. Its recurrence is more common than other UTIs, with the recurrence rate being 5.7% in men and 9% in women.

Patients with diabetes are at increased risk of developing urinary tract infections such as acute cystitis, and therefore, the increasing global prevalence of diabetes is likely to contribute to cystitis growth. According to an NCBI article, type 2 diabetes raises UTI risk and patients with type 2 diabetes experience frequent & severe UTIs. According to the International Diabetes Federation (IDF) data from 2021, approximately 643 million individuals will have diabetes by 2030 and 783 million by 2045. Moreover, the estimated prevalence of asymptomatic bacteriuria in diabetic females is 26%, compared to 6% in nondiabetic females. Such factors are expected to boost the prevalence of cystitis globally.

However, due to the rise in awareness about such diseases, the demand for specialist treatment has increased in recent years. According to the U.S. Department of Health and Human Services, in the U.S., the number of practicing urologists in 2020 was 4.07 per 100,000 populations. The report further stated that due to the rise in demand, a shortage of urologists was observed, which is likely to exceed nearly 3,600 physicians by 2025. This can impede market growth in the coming years. Moreover, COVID-19 has had a detrimental impact on the industry. Individuals with UTIs have experienced substantial disruptions in testing and emergency care.

Key players are introducing novel products to strengthen their portfolios. For instance, in September 2021, OpGen, Inc. announced initiating clinical trials of the Unyvero Urinary Tract Infection Panel. The panel can analyze a broad range of pathogens and antimicrobial resistance markers directly from a urine sample. Successful clinical trials and the launch of such technologically advanced & efficient products are anticipated to drive market growth over the coming years. Similarly, in July 2020, Uqora, Inc. (Pharmavite, LLC), a urinary health biotechnology company, launched a UTI diagnostic and management kit. The kit includes a rapid UTI diagnostic device, Clarify, compatible with a PoC and homecare setting.

Urinary Tract Infection Testing Market Highlights

  • Cystitis dominated the market in 2022, with an estimated market share of 41.42%. This can be attributed to the high incidence & recurrence rate of cystitis, increased number of product approvals, and the high number of diabetes patients who are more prone to cystitis
  • The reference laboratories segment held a share of 26.66% in 2022 attributed to the ongoing efforts of reference laboratories to enhance patient outcomes by offering diagnostic facilities at retail level.
  • North America dominated the overall urinary tract infection market in terms of value. This can be attributed to better reimbursement facilities and a rise in the adoption of novel diagnostic products due to increased awareness

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Urinary Tract Infection Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Urinary Tract Infection Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Urinary Tract Infection Testing: Type Estimates & Trend Analysis

  • 4.1. Urinary Tract Infection Testing Market: Key Takeaways
  • 4.2. Urinary Tract Infection Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Urethritis
    • 4.3.1. Urethritis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Cystitis
    • 4.4.1. Cystitis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Pyelonephritis
    • 4.5.1. Pyelonephritis market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Urinary Tract Infection Testing: End Use Estimates & Trend Analysis

  • 5.1. Urinary Tract Infection Testing Market: Key Takeaways
  • 5.2. Urinary Tract Infection Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. General Practitioners (GPs)
    • 5.3.1. General practitioners (GPs) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Urologists
    • 5.4.1. Urologists market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Urogynecologists
    • 5.5.1. Urogynecologists market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Hospital Laboratories
    • 5.6.1. Hospital laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Reference Laboratories
    • 5.7.1. Reference laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Hospital Emergency Departments
    • 5.8.1. Hospital emergency departments market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.9. Urgent Care
    • 5.9.1. Urgent care market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Urinary Tract Infection Testing Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Urinary Tract Infection Testing Market by Region: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. QIAGEN
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Accelerate Diagnostics, Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bio-Rad Laboratories, Inc.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. F. Hoffmann-La Roche Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Danaher
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Siemens Healthcare GmbH
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Randox Laboratories Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Thermo Fisher Scientific, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. BIOMERIEUX
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. T2 Biosystems, Inc.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 4 North America urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 6 U.S. urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 8 Canada urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Europe urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 10 Europe urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 12 Germany urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 13 Germany urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 14 UK urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 15 UK urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 France urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 17 France urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 18 Italy urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 19 Italy urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 20 Spain urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 21 Spain urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 22 Sweden urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 23 Sweden urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 24 Norway urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 25 Norway urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Denmark urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 27 Denmark urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 31 China urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 32 China urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Japan urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 34 Japan urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 India urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 36 India urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Thailand urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 38 Thailand urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 39 South Korea urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Latin America urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 42 Latin America urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Latin America urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Brazil urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 45 Brazil urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Mexico urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 47 Mexico urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Argentina urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 49 Argentina urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Middle East and Africa urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 51 Middle East and Africa urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa urinary tract infection testing market, by region, 2018 - 2030 (USD Million)
  • Table 53 South Africa urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 54 South Africa urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Saudi Arabia urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 UAE urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 58 UAE urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Kuwait urinary tract infection testing market, by type, 2018 - 2030 (USD Million)
  • Table 60 Kuwait urinary tract infection testing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Urinary tract infection testing: Market outlook
  • Fig. 9 Urinary tract infection testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Urinary tract infection testing market driver impact
  • Fig. 15 Urinary tract infection testing market restraint impact
  • Fig. 16 Urinary tract infection testing market strategic initiatives analysis
  • Fig. 17 Urinary tract infection testing market: Type movement analysis
  • Fig. 18 Urinary tract infection testing market: Type outlook and key takeaways
  • Fig. 19 Urethritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cystitis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Pyelonephritis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Urinary tract infection testing market: End use movement analysis
  • Fig. 23 Urinary tract infection testing market: End use outlook and key takeaways
  • Fig. 24 General practitioners (GPs) market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Urologists market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Urogynecologists market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Hospital laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Reference laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Hospital emergency departments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Urgent care market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Global urinary tract infection testing market: Regional movement analysis
  • Fig. 33 Global urinary tract infection testing market: Regional outlook and key takeaways
  • Fig. 34 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)